The double burden of malnutrition (DBM) is becoming more prevalent throughout the world, but most alarming is the fact that it is also prevalent in lower-income countries, those with limited research and policy funding. To that end, a number of research gaps have been identified related to the biology, research methodologies/data systems, and programs and policies that could be improved to best address the DBM across the globe, especially in diverse settings with limited resources. Clearly, understanding the biology of the DBM is fundamental to developing policies, but research needs to become more interdisciplinary and communicate better with policymakers. At the same time, research methods need to become more innovative, and data systems must advance to accommodate new research methods and approaches. Filling these gaps will allow for broad and effective policies to be implemented through both public and private groups, an area that could be leveraged through transparent public-private engagement and programs. Without novel and integrated approaches to research, efforts to reverse the DBM will be limited. Therefore, the time has come for truly cooperative and collaborative efforts on all fronts to work together and promote the health of future generations across the globe.

1.
Haisma H, Pelto G, Venkatapuram S, Yousefzadeh S, Kramer L, Anand P, members of the Working Group “Towards a multi-dimensional index of child growth”: Towards a multi-dimensional index of child growth to combat the double burden of malnutrition. Ann Nutr Metab 2019. doi: 10.1159/000503670.
Open Access License / Drug Dosage / Disclaimer
Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution 3.0 IGO License (CC BY 3.0 IGO). Usage, distribution and reproduction in any medium or format, even for commercial purposes, is permitted, provided the original work is properly cited.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.